George Cheng, MD, FCCP

George Cheng, MD, FCCP

With so many educational sessions on the CHEST 2023 schedule, there will be something that applies to every area of clinical practice.

George Cheng, MD, FCCP, Vice-Chair of the Thoracic Oncology and Chest Procedures Network at CHEST and Co-Chair of the Lung Cancer, Interventional Pulmonary, and Radiology Curriculum Group for CHEST 2023, is looking forward to his time in Hawaiʻi and is encouraging others to join.

“The CHEST Annual Meeting is really for everybody—from resident to fellow to attending, there is something for every level and for a variety of practicing areas, too. Our curriculum, in particular, caters to those in thoracic surgery, interventional pulmonology, radiology, oncology, and more,” Dr. Cheng said. “When you go to CHEST, not only do you have an opportunity to meet and network with the ‘who's who’ in pulmonary [medicine], but you also have the chance to learn from those people in an intimate setting.”

Dr. Cheng spotlighted a handful of sessions from his curriculum group that cover the breadth of information available at the meeting:

• Lung Cancer in Idiopathic Pulmonary Fibrosis and Lung Transplant: Diagnostic and Therapeutic Dilemmas
  Sunday, October, 8 at 10:45 am
• Innovative Imaging Techniques for Interstitial Lung Diseases
  Monday, October 9, at 10:30 am
• A Breath of Fresh Air: Bronchoscopic Interventions for Patients With COPD
  Monday, October 9, at 3 pm
• Rapid-Fire Topics in Lung Cancer and Pulmonary Procedures
  Tuesday, October 10, at 8:30 am
• Pardon the Interruption 2023: Controversies in Interventional Pulmonology
  Wednesday, October 11, at 8:30 am

“Two major topics that are going to be covered on lung cancer relate specifically to screening and the disparities we’ve found associated with lung cancer screenings,” Dr. Cheng said.

He’s also looking forward to a debate between leading researchers in the field of bronchoscopic-guided ablation for peripheral long nodules.

“As those in our specialty know, this is a novel technology that still requires significant study in order to ensure the highest degree of safety and efficacy in providing this therapy to our patients,” he said. “Coming together at an international meeting like CHEST, especially given this year’s Pacific Coast location, offers a tremendous opportunity to hear from experts on new techniques and technology—what the advances entail and the potential benefits and pitfalls we should be considering.”